Liping Sun1, Xinzhou Zhang1. 1. Shenzhen Key Laboratory of Renal, Department of Nephrology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
Abstract
BACKGROUND: Mitral valve prolapse (MVP) is a common cardiovascular disease defined as a late systolic click or mitral valve lobes that move up into the left atrium during ventricular systole, with or without mitral insufficiency. Dachsous catherin-related 1 (DCHS1) is one of the two known pathogenic genes associated with MVP. However, there is little information about the renal dysfunction caused by MVP and DCHS1 mutations. METHODS: We analyzed the genetic etiology in a rare case of 9-year-old boy affected by chronic renal failure with MVP. Subsequently, we constructed stable cell lines overexpressing wild-type DCHS1 or mutant DCHS1 (c.8309G>A, p.R2770Q) to evaluate the influence of the DCHS1 mutation on the proliferation, apoptosis, and autophagy. RESULTS: Complete exome sequencing and pedigree verification revealed a mutation p.R2770Q (c.8309G>A) in exon 21 of the DCHS1 gene carried by the patient, which may affect the DNA binding. No such mutation was detected in his parents, indicating that this was a new mutation. Potential functional impact of sequence variants was predicted using in silico prediction programs including SIFT, Polyphen2, and Condel. This variant was determined to be a pathogenic mutation that has not been reported elsewhere. Subsequently, we used a stable DCHS1 gene-mutated HK-2 cell line to analyse proliferation, apoptosis, and autophagy, showed that kidney volume decreased with increasing cell death associated with a reduced proliferation. CONCLUSIONS: Our analysis revealed a heterozygous variation of DCHS1 in a child with MVP. Our observations highlight previously unrecognized phenotypes of the currently recognized MVP genotype, including distinct chronic renal failure.
BACKGROUND:Mitral valve prolapse (MVP) is a common cardiovascular disease defined as a late systolic click or mitral valve lobes that move up into the left atrium during ventricular systole, with or without mitral insufficiency. Dachsous catherin-related 1 (DCHS1) is one of the two known pathogenic genes associated with MVP. However, there is little information about the renal dysfunction caused by MVP and DCHS1 mutations. METHODS: We analyzed the genetic etiology in a rare case of 9-year-old boy affected by chronic renal failure with MVP. Subsequently, we constructed stable cell lines overexpressing wild-type DCHS1 or mutant DCHS1 (c.8309G>A, p.R2770Q) to evaluate the influence of the DCHS1 mutation on the proliferation, apoptosis, and autophagy. RESULTS: Complete exome sequencing and pedigree verification revealed a mutation p.R2770Q (c.8309G>A) in exon 21 of the DCHS1 gene carried by the patient, which may affect the DNA binding. No such mutation was detected in his parents, indicating that this was a new mutation. Potential functional impact of sequence variants was predicted using in silico prediction programs including SIFT, Polyphen2, and Condel. This variant was determined to be a pathogenic mutation that has not been reported elsewhere. Subsequently, we used a stable DCHS1 gene-mutated HK-2 cell line to analyse proliferation, apoptosis, and autophagy, showed that kidney volume decreased with increasing cell death associated with a reduced proliferation. CONCLUSIONS: Our analysis revealed a heterozygous variation of DCHS1 in a child with MVP. Our observations highlight previously unrecognized phenotypes of the currently recognized MVP genotype, including distinct chronic renal failure.
Authors: Chrishan J Nalliah; Rajiv Mahajan; Adrian D Elliott; Haris Haqqani; Dennis H Lau; Jitendra K Vohra; Joseph B Morton; Christopher Semsarian; Thomas Marwick; Jonathan M Kalman; Prashanthan Sanders Journal: Heart Date: 2018-09-21 Impact factor: 5.994
Authors: L A Freed; D Levy; R A Levine; M G Larson; J C Evans; D L Fuller; B Lehman; E J Benjamin Journal: N Engl J Med Date: 1999-07-01 Impact factor: 91.245
Authors: Hui-Chen Han; Francis J Ha; Andrew W Teh; Paul Calafiore; Elizabeth F Jones; Jennifer Johns; Anoop N Koshy; David O'Donnell; David L Hare; Omar Farouque; Han S Lim Journal: J Am Heart Assoc Date: 2018-12-04 Impact factor: 5.501
Authors: Ronen Durst; Kimberly Sauls; David S Peal; Annemarieke deVlaming; Katelynn Toomer; Maire Leyne; Monica Salani; Michael E Talkowski; Harrison Brand; Maëlle Perrocheau; Charles Simpson; Christopher Jett; Matthew R Stone; Florie Charles; Colby Chiang; Stacey N Lynch; Nabila Bouatia-Naji; Francesca N Delling; Lisa A Freed; Christophe Tribouilloy; Thierry Le Tourneau; Hervé LeMarec; Leticia Fernandez-Friera; Jorge Solis; Daniel Trujillano; Stephan Ossowski; Xavier Estivill; Christian Dina; Patrick Bruneval; Adrian Chester; Jean-Jacques Schott; Kenneth D Irvine; Yaopan Mao; Andy Wessels; Tahirali Motiwala; Michel Puceat; Yoshikazu Tsukasaki; Donald R Menick; Harinath Kasiganesan; Xingju Nie; Ann-Marie Broome; Katherine Williams; Amanda Johnson; Roger R Markwald; Xavier Jeunemaitre; Albert Hagege; Robert A Levine; David J Milan; Russell A Norris; Susan A Slaugenhaupt Journal: Nature Date: 2015-08-10 Impact factor: 49.962